Nachrichten zur Quest Diagnostics Aktie

Guardant Health (GH) Q3 2025 Earnings Transcript

Image source: The Motley Fool.DATEWednesday, Oct. 29, 2025 at 4:30 p.m. ETCALL PARTICIPANTSCo-Chief Executive Officer — Helmy EltoukhyCo-Chief Executive Officer…

Quest Diagnostics director Pfeiffer sells $270k in stock By Investing.com

Quest Diagnostics director Pfeiffer sells $270k in stock…

Quest Diagnostics stock hits all-time high at 191.87 USD By Investing.com

Quest Diagnostics stock hits all-time high at 191.87 USD…

Will Quest Diagnostics (DGX) Beat Estimates Again in Its Next Earnings Report?

Quest Diagnostics (DGX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients…

Quest Diagnostics stock hits all-time high at $190.93 By Investing.com

Quest Diagnostics stock hits all-time high at $190.93…

Quest Diagnostics Raises 2025 Guidance

Key PointsQ2 revenue of $2.76 billion and adjusted EPS of $2.62 beat analyst estimates.Management raised full-year 2025 guidance for both…

Quest Diagnostics Boosts Its 2025 Outlook

Quest Diagnostics (NYSE:DGX) reported its second-quarter 2025 results on July 22, achieving consolidated revenue of $2.76 billion (up 15.2% year…

Will Quest Diagnostics (DGX) Beat Estimates Again in Its Next Earnings Report?

Quest Diagnostics (DGX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients…

Motley Fool Investors Look Back at the First Half of 2025

In this podcast, Motley Fool senior analyst Anthony Schiavone and Motley Fool Asset Managements Chief Investment Strategist Bill Mann…

Quest Diagnostics (DGX) Upgraded to Buy: Heres What You Should Know

Quest Diagnostics (DGX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to…

HOLX vs. DGX: Which Womens Health-Focused Stock Is the Better Pick?

The womens health market is booming, with Hologic and Quest Diagnostics leading the charge. But which one stands out more…

Quest Diagnostics (DGX) Down 1.8% Since Last Earnings Report: Can It Rebound?

Quest Diagnostics (DGX) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

Should You Continue to Retain DGX Stock in Your Portfolio?

Quest Diagnostics continues to stay on investors radars due to its robust Advanced Diagnostics offerings and strength in acquisitions.…

Take the Zacks Approach to Beat the Markets: ADMA Biologics, Limbach, Quest Diagnostics in Focus

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the…

Quest Diagnostics: A Leader But Waiting For Better Price

…

Quest Diagnostics (DGX) Earnings Expected to Grow: Should You Buy?

Quest Diagnostics (DGX) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…

Quest Diagnostics: Diagnostic-Spezialist profitiert von steigenden Behandlungszahlen und neuen KI-Tools zum Nachweis von Krebs!

Geschäftstreiber: Quest Diagnostics (DGX) gehört zu den weltweit führenden Anbietern klinischer Test- und Diagnostik-Verfahren. Neben Standard-Bluttests und diagnostischen Testverfahren zum…

Quest Diagnostics (DGX) is a Great Momentum Stock: Should You Buy?

Does Quest Diagnostics (DGX) have what it takes to be a top stock pick for momentum investors? Lets find out.…

Why Quest Diagnostics Stock Was Blasting Higher Today

Quest Diagnostics (NYSE: DGX) stock was teasing its all-time high on Thursday, no mean feat for a company thats been…

Quest Diagnostics EPS Tops Predictions

Quest Diagnostics saw robust growth in earnings and revenue, surpassing expectations for Q4 2024.…

Up More Than 500% in 12 Months, Is It Too Late to Buy Summit Therapeutics Stock?

It can be exciting to buy a stock that has been red hot and to jump on the bandwagon --…

EQS-News: Mainz Biomed gibt Vereinbarung mit Quest Diagnostics über die Bereitstellung von Labor-Services im Rahmen der klinischen Studie für den Darmkrebsfrüherkennungstest bekannt (deutsch)

Mainz Biomed gibt Vereinbarung mit Quest Diagnostics über die Bereitstellung von Labor-Services im Rahmen der klinischen Studie für den Darmkrebsfrüherkennungstest…

Quest Diagnostics stock hits 52-week high at $165.11 By Investing.com

Quest Diagnostics stock hits 52-week high at $165.11…

Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year

Cautious investors have long known that healthcare spending rises steadily regardless of the direction of the overall economy. Its considered…

Quest Diagnostics declares $0.75 dividend

…

Heres Why You Should Retain DGX Stock in Your Portfolio Now

Investors feel optimistic about Quest Diagnostics strength in Advanced Diagnostics. Robust base business volumes are also encouraging.…

Quest Diagnostics: Neue KI-Tools zur Krebs-Früherkennung schieben Ergebnis deutlich an!

Geschäftstreiber: Quest Diagnostics (DGX) gehört zu den weltweit führenden Anbietern im Bereich klinischer Test- und Diagnostik-Verfahren rund um verschiedene Segmente.…

Quest Diagnostics stock hits 52-week high of $159.46 By Investing.com

Quest Diagnostics stock hits 52-week high of $159.46…

Quest Diagnostics (DGX) Q3 2024 Earnings Call Transcript

…

DGX Stock Rises on Q3 Earnings and Revenue Beat, 2024 Sales View Up

Quest Diagnostics third-quarter 2024 performance reflects impressive DIS business growth and the benefits of new acquisitions.…

Quest Diagnostics: The Better Half Of An Emerging Healthcare Duopoly

…

DGX Gears Up for Q3 Earnings: What Lies Ahead for the Stock?

Quest Diagnostics is expected to deliver robust base business growth in the third quarter of 2024.…

Quest Diagnostics Stock Gains From New Offerings, Customer Wins

A key driver in Brain Health growth is Quest Diagnostics Alzheimers disease portfolio, featuring the AD-Detect blood testing services and…

DGX Stock to Benefit From New Partnership With Sentara Health Plans

Quest Diagnostics extends services in Virginia and Florida via a partnership with Sentara Health Plans.…

DGX Stock Likely to Gain From Allina Healths Select Lab Assets Buyout

With the completion of the acquisition, Allina Healths clinic physicians will now have access to Quest Diagnostics laboratory services.…

Investing in Quest Diagnostics (NYSE:DGX) five years ago would have delivered you a 60% gain

When you buy and hold a stock for the long term, you definitely want it to provide a positive return.…

BCAL Commences US Operations

BCAL Diagnostics Limited (ASX: BDX) (“BCAL” or “the Company”) is pleased to announce that it has established a North Carolina,…

Quest Diagnostics Expands in North America With New Acquisition

DGX acquires 100% of LifeLabs from OMERS, at approximately $1 billion. It will help LifeLabs to improve healthcare for Canadians.…

Quest Diagnostics (DGX) New Deal Aids Diagnostic Access in Ohio

Quest Diagnostics (DGX) signs an agreement to acquire select assets of University Hospitals outreach laboratory services business.…

Quest Diagnostics (DGX) Debuts Micronutrient Deficiency Panels

Quest Diagnostics (DGX) introduces 13 blood tests to identify micronutrient deficiencies.…

Quest Diagnostics (DGX) New Study Exposes Alarming Data on STI

Quest Diagnostics (DGX) joint study with the University of Alabama finds pregnant women undertested for STIs, raising serious concerns on…

Quest Diagnostics stock hits 52-week high at $151.94 By Investing.com

Quest Diagnostics stock hits 52-week high at $151.94…

Quest Diagnostics (DGX) Gains From Innovation, Customer Wins

A key driver in Brain Health growth is Quest Diagnostics (DGX) Alzheimers disease portfolio, featuring the AD-Detect blood testing services…

Should Quest Diagnostics (DGX) be in Your Portfolio Now?

Quest Diagnostics (DGX) robust base business performance instills optimism for long-term growth.…

Quest Diagnostics (DGX) Haystack Oncology Forges New MRD Deal

Quest Diagnostics (DGX) subsidiary, Haystack Oncology, partners on the use of its MRD technology.…

Quest Diagnostics (DGX) Q2 Earnings and Revenues Top Estimates

Quest Diagnostics (DGX) delivered earnings and revenue surprises of 1.73% and 0.50%, respectively, for the quarter ended June 2024. Do…

Quest Diagnostics: On A Quest For Growth

…

What Awaits Quest Diagnostics (DGX) in Q2 Earnings Release?

Quest Diagnostics (DGX) is likely to have maintained its robust base business performance in the second quarter of 2024. However,…

Quest Diagnostics to acquire certain assets from OhioHealth

…

Global Precision Diagnostics Market Size To Worth USD 254.48 Billion By 2033 | CAGR Of 13%

The Global Precision Diagnostics Market Size was Valued at USD 74.98 Billion in 2023 and the Worldwide Precision Diagnostics Market…